Inpatient Pharmacy Operations

Jim Stevenson (Pharm D, FASHP) is President of Visante’s Hospital and Health Systems Services practice working with practice leads Gregory Burger (MS, RPh, FASHP) and Tammy Zukowski (MBA)

Pharmacy Department Assessment

A performance-based assessment of pharmacy operations and analysis of new entrepreneurial opportunities conducted by nationally recognized pharmacy experts. Our assessment process uses proven performance concepts and current best practices plus an analysis of critical business metrics. The outcome is a ranking of the potential for a wide variety of business opportunities to improve pharmacy’s contribution to institutional performance goals.

Pharmacy Revenue Cycle Analysis

Visante has developed a proprietary diagnostic data analysis as a part of its end-to-end review that searches for lost revenue, incorrect pricing, coding and system translations. Our team searches out pharmacy systems issues and then suggests efficient ways to make corrections. Often our recommendations involve simple changes that recover millions of dollars due to lost charges, suboptimal pricing, incorrect coding or inaccurate translation of dispensing-units to billing-units.

Pharmacy System Service Development & Evaluation of Staffing Models

Let Visante’s national exposure to pharmacy best practices provide a system-wide evaluation and plan to improve medication management services. Our consultants look for opportunities to optimize economies of scale and practice standardization. Current staffing complements are assessed and compared with models from similar facilities to maximize operational and economic efficiency.

Safe Handling of Hazardous Drugs

Studies have failed to establish an acceptable level of personnel exposure to hazardous drugs. There is increased attention to safe handling strategies and this is the focus of the new USP Chapter 800 standards. Visante is pleased to have nationally recognized experts experienced in establishing best practices concerning safe handling and have tested various closed system transfer devices (CSTDs). Some CSTDs are not only extremely safe but also allow for drug vial optimization (DVO) that extends the period of time in which stable drug contents can be used for sterile compounding and dispensing to patients.

Evaluating and Developing Sterile Compounding Services

Maintaining in-house compounding capabilities vs. purchasing externally manufactured pharmaceuticals is under consideration by most Directors of Pharmacy. Visante has conducted a number of assessments for institutions considering the implications of investing in these facilities and the required dedicated staff (falling under Section 503A of the Drug Quality and Security Act of 2013) vs. purchasing them from  out-sourcing (Section 503B) facilities. Visante has the specialists who can assess the multiple variables involved in this assessment and develop a business plan with conservative ROI assumptions. We also can help with facility design and implementation including the details of production processes and safe storage of materials. Use this link to download a summary of our Sterile Compounding Services.